A preventive treatment for lower respiratory tract infections caused by RSV got the go ahead from the European Commission on Friday, according to one of the companies that make it.The treatment is the first of its kind to protect all infants in their first year of life.A spokesperson from drugmaker Sanofi says that they've also submitted their research to the US Food and Drug Administration for approval.
#years #united-states #development #collaboration #spokesperson #disease-control #astrazeneca #news-release #european-commission #hospitalization
[
add
]
[
|
|
...
]